Interactions between the epidermal growth factor receptor and type I protein kinase A: biological significance and therapeutic implications.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Clinical Cancer Research

• Publication date

  1998-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9563874
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The epidermal growth factor receptor as a target for therapy in breast carcinoma

  2004cited by this paper
• Tumour cyclic AMP binding proteins: an independent prognostic factor for disease recurrence and survival in breast cancer

  2004cited by this paper
• Cripto Enhances the Tyrosine Phosphorylation of Shc and Activates Mitogen-activated Protein Kinase (MAPK) in Mammary Epithelial Cells*

  1997cited by this paper
• Activation of cAMP–PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury

  1997cited by this paper
• Synergistic inhibition of growth and induction of apoptosis by 8-chloro-cAMP and paclitaxel or cisplatin in human cancer cells.

  1997cited by this paper
• 8-Chloro-cyclic AMP inhibits autocrine and angiogenic growth factor production in human colorectal and breast cancer.

  1997cited by this paper
• The RIα subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-Receptor

  1997cited by this paper
• Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: in vitro and in vivo studies.

  1997cited by this paper
• Targeted inhibition of tumour cell growth by a bispecific single-chain toxin containing an antibody domain and TGF alpha.

  1996cited by this paper
• Differential immunohistochemical detection of transforming growth factor α, amphiregulin and CRIPTO in human normal and malignant breast tissues

  1996cited by this paper
• Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides.

  1996cited by this paper
• Molecular Glue: Kinase Anchoring Minireview

  1996cited by this paper
• Overexpression of RII beta regulatory subunit of protein kinase A induces growth inhibition and reverse-transformation in SK-N-SH human neuroblastoma cells.

  1996cited by this paper
• Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A.

  1996cited by this paper
• Requirement for the Adapter Protein GRB2 in EGF Receptor Endocytosis

  1996cited by this paper
• Molecular glue: kinase anchoring and scaffold proteins.

  1996cited by this paper
• A single-injection protein kinase A-directed antisense treatment to inhibit tumour growth

  1995cited by this paper
• Epidermal growth factor-related peptides and their receptors in human malignancies.

  1995cited by this paper
• Immunotoxins that target an oncogenic mutant epidermal growth factor receptor expressed in human tumors.

  1995cited by this paper
• Cooperative antiproliferative effects of 8-chloro-cyclic AMP and 528 anti-epidermal growth factor receptor monoclonal antibody on human cancer cells.

  1995cited by this paper
• Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model.

  1995cited by this paper
• Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells.

  1995cited by this paper
• 4,5-bis(4-fluoroanilino)phthalimide: A selective inhibitor of the epidermal growth factor receptor signal transduction pathway with potent in vivo antitumor activity.

  1995cited by this paper
• cAMP-dependent protein kinase: role in normal and malignant growth.

  1995cited by this paper
• Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo

  1995cited by this paper
• Protein modules and signalling networks

  1995cited by this paper
• Phase I clinical study with 8-chloro-cAMP and evaluation of immunological effects in cancer patients

  1995cited by this paper
• Flow-cytometric detection of the RI alpha subunit of type I cAMP-dependent protein kinase in human cells.

  1994cited by this paper
• Regulation of ras proteins and their involvement in signal-transduction pathways (review).

  1994cited by this paper
• Location of cAMP-dependent protein kinase type I with the TCR-CD3 complex.

  1994cited by this paper
• Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.

  1994cited by this paper
• Selective toxicity of TGF-alpha-PE40 to EGFR-positive cell lines: selective protection of low EGFR-expressing cell lines by EGF.

  1994cited by this paper
• Retroviral vector-mediated overexpression of the RII beta subunit of the cAMP-dependent protein kinase induces differentiation in human leukemia cells and reverts the transformed phenotype of mouse fibroblasts.

  1994cited by this paper
• Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides.

  1994cited by this paper
• The RIalfa subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells.

  1994cited by this paper
• The RI alpha subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells.

  1994cited by this paper
• The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1

  1993cited by this paper
• Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A

  1993cited by this paper
• cAMP antagonizes p21ras‐directed activation of extracellular signal‐regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor.

  1993cited by this paper
• Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling

  1993cited by this paper
• Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts.

  1993cited by this paper
• Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras

  1993cited by this paper
• Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3',5'-monophosphate.

  1993cited by this paper
• Infection with a transforming growth factor α anti‐sense retroviral expression vector reduces the in vitro growth and transformation of a human colon cancer cell line

  1993cited by this paper
• Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.

  1993cited by this paper
• 8-Cl-cAMP induces truncation and down-regulation of the RI alpha subunit and up-regulation of the RII beta subunit of cAMP-dependent protein kinase leading to type II holoenzyme-dependent growth inhibition and differentiation of HL-60 leukemia cells.

  1993cited by this paper
• An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells.

  1993cited by this paper
• Early events of human T lymphocyte activation are associated with type I protein kinase A activity.

  1993cited by this paper
• Reduction of RIα Subunit of cAMP‐dependent Protein Kinase Expression Induces Growth Inhibition of Human Mammary Epithelial Cells Transformed by TGF‐α, c‐Ha‐ras, and c‐erbB‐2 Genes

  1993cited by this paper
• Inhibition by cAMP of Ras-dependent activation of Raf.

  1993cited by this paper
• Expression of transforming growth factor α antisense mRNA inhibits the estrogen‐induced production of TGFα and estrogen‐induced proliferation of estrogen‐responsive human breast cancer cells

  1993cited by this paper
• Expression of transforming growth factor alpha antisense mRNA inhibits the estrogen-induced production of TGF alpha and estrogen-induced proliferation of estrogen-responsive human breast cancer cells.

  1993cited by this paper
• Thyroid-stimulating hormone-regulated growth and cell cycle distribution of thyroid cells involve type I isozyme of cyclic AMP-dependent protein kinase.

  1993cited by this paper
• Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction.

  1993cited by this paper
• The regulatory subunit of cAMP-dependent protein kinase as a target for chemotherapy of cancer and other cellular dysfunctional-related diseases.

  1993cited by this paper
• Autocrine Secretion—10 Years Later

  1992cited by this paper
• v-ras and protein kinase C dedifferentiate thyroid cells by down-regulating nuclear cAMP-dependent protein kinase A.

  1992cited by this paper
• Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors.

  1992cited by this paper
• Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase.

  1991cited by this paper
• Growth factors and cancer.

  1991cited by this paper
• The tissue-specific extinguisher locus TSE1 encodes a regulatory subunit of cAMP-dependent protein kinase.

  1991cited by this paper
• Dynamics of the distribution of cyclic AMP-dependent protein kinase in living cells.

  1990cited by this paper
• 8-Chloro-cAMP inhibits transforming growth factor alpha transformation of mammary epithelial cells by restoration of the normal mRNA patterns for cAMP-dependent protein kinase regulatory subunit isoforms which show disruption upon transformation.

  1990cited by this paper
• Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.

  1990cited by this paper
• cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes.

  1990cited by this paper
• Transformation of an established mouse mammary epithelial cell line following transfection with a human transforming growth factor alpha cDNA

  1989cited by this paper
• Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells.

  1989cited by this paper
• Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.

  1989cited by this paper
• Site‐selective 8‐chloroadenosine 3′,5′‐cyclic monophosphate inhibits transformation and transforming growth factor α production in Ki‐ras‐transformed rat fibroblasts

  1989cited by this paper
• Inhibition of growth and modulation of gene expression in human lung carcinoma in athymic mice by site-selective 8-Cl-cyclic adenosine monophosphate.

  1989cited by this paper
• Anti-EGF receptor monoclonal antibodies: biological studies and potential clinical applications.

  1989cited by this paper
• Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogues.

  1988cited by this paper
• Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice.

  1988cited by this paper
• Rapid and reversible translocation of the catalytic subunit of cAMP‐dependent protein kinase type II from the Golgi complex to the nucleus.

  1985cited by this paper
• Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies.

  1984cited by this paper
• Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity.

  1984cited by this paper
• Compartmentalization of regulatory subunits of cyclic adenosine 3':5'-monophosphate-dependent protein kinases in MCF-7 human breast cancer cells.

  1983cited by this paper
• Type I and type II cyclic AMP-dependent protein kinase as opposite effectors of lymphocyte mitogenesis

  1977cited by this paper
• The distribution and dissociation of cyclic adenosine 3':5'-monophosphate-dependent protein kinases in adipose, cardiac, and other tissues.

  1975cited by this paper

• Anti-Inflammatory Herb Combination : A Promising Strategy for Preventing Colon and Other Cancer

  2019cites this paper
• Multiplexing PKA and ERK1&2 kinases FRET biosensors in living cells using single excitation wavelength dual colour FLIM

  2017cites this paper
• TARGETED DELVERY OF THERAPEUTIC AGENTS

  2017cites this paper
• Role of epidermal growth factor receptor in lung cancer and targeted therapies.

  2017cites this paper
• Genomic Analysis of Pigmented Epithelioid Melanocytomas Reveals Recurrent Alterations in PRKAR1A, and PRKCA Genes

  2017cites this paper
• Développement de nouvelles méthodes pour dépasser les limitations rencontrées dans le suivi de biosenseur FRET par microscopie de fluorescence quantitative

  2016cites this paper
• Epidermal growth factor receptor and notch signaling in non‐small‐cell lung cancer

  2016cites this paper
• Dichotomous role of protein kinase A type I (PKAI) in the tumor microenvironment: a potential target for 'two-in-one' cancer chemoimmunotherapeutics.

  2015cites this paper
• A role for cAMP-driven transactivation of EGFR in cancer aggressiveness - therapeutic implications.

  2014influential citation
• Inhibition of epidermal growth factor receptor restores decidualization markers in stromal fibroblasts from women with endometriosis

  2014cites this paper
• Mecanismo de ação do estrógeno no gene Amphiregulin em células MCF7 e MDA-MB-231 via P13K

  2014cites this paper
• Different frequency of epidermal growth factor rs76189946 polymorphism genotype in an Iranian colorectal cancer

  2013cites this paper
• Application Of Scanning Correlation Spectroscopy Techniques To Quantify DNA Double Strand Break Repair Kinetics In The Living Cell After Exposure To γ-rays And Radiomimetic Chemicals

  2013cites this paper
• Redox regulation of type Iα PKA in the heart

  2013cites this paper
• Crossing Paths in Human Renal Cell Carcinoma (hRCC)

  2012cites this paper
• Potential Pharmacological Interventions in Polycystic Kidney Disease

  2012cites this paper
• Number and brightness analysis to quantify the kinetics of EGFR and its mutants in living cells before and after γ-irradiation

  2012cites this paper
• The Role of EGFR and HER2- Activating Mutations in Maxillary Sinus Cancer.

  2012cites this paper
• Direct modulation of the protein kinase a catalytic subunit α by growth factor receptor tyrosine kinases

  2012cites this paper
• Progressive increase of glucose transporter-3 (GLUT-3) expression in estrogen-induced breast carcinogenesis

  2012cites this paper
• Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: implications in ADPKD cell proliferation

  2012cites this paper
• The landscape of EGFR pathways and personalized management of non-small-cell lung cancer.

  2011cites this paper
• The Role of PKA Activation in the Branching Morphogenesis of the Ureteric Bud

  2011cites this paper
• A Computational Linguistics Approach to the Identification of Biological Factors that Contribute to the Development and Progression of Lung Cancer

  2011cites this paper
• Protein Kinase A: The Enzyme and Cyclic AMP Signaling

  2011cites this paper
• PKA knockdown enhances cell killing in response to radiation and androgen deprivation

  2011cites this paper
• Leptin potentiates antiproliferative action of cAMP elevation via protein kinase A down‐regulation in breast cancer cells

  2010cites this paper
• Curcumin and Other Anti-Inflammatory Herbs In Cancer Prevention and Adjunctive Management

  2010cites this paper
• Protein kinase A as a biological target in cancer therapy

  2009cites this paper
• Nanoscale Imaging of Epidermal Growth Factor Receptor Clustering

  2009cites this paper
• The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD)

  2009cites this paper
• Ovarian Cancer and Genetic Susceptibility: Association of A61G Polymorphism in the EGF Gene

  2009cites this paper
• Expressão de genes homeobox em células de carcinoma epidermóide de boca estimuladas com EGF e TGF-beta

  2008cites this paper
• Influence of cyclic AMP on facial nerve regeneration in rats

  2008cites this paper
• Influência do AMP cíclico na regeneração do nervo facial em ratos

  2008cites this paper
• The Role of EGFR Inhibition in Colorectal Cancer

  2007cites this paper
• cAMP and protein kinase A in endocrine (and other) tumors

  2007cites this paper
• Targeting different signaling pathways with antisense oligonucleotides combination for cancer therapy.

  2007cites this paper
• Crosstalk between EGFR and TrkB enhances ovarian cancer cell migration and proliferation.

  2006cites this paper
• Monoclonal antibodies targeting the epidermal growth factor receptor.

  2005cites this paper
• UvA-DARE ( Digital Academic Repository ) Plectin ' s actin-binding domain : a versatile element Litjens

  2005cites this paper
• CpG Immunomer DNA Enhances Antisense Protein Kinase A RIα Inhibition of Multidrug-Resistant Colon Carcinoma Growth in Nude Mice: Molecular Basis for Combinatorial Therapy

  2005cites this paper
• Proliferation of cerebellar neurons induced by astrocytes treated with thyroid hormone is mediated by a cooperation between cell contact and soluble factors and involves the epidermal growth factor‐protein kinase a pathway

  2005cites this paper
• Anti-cancer drugs: molecular mechanisms of action.

  2005cites this paper
• Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy

  2004cites this paper
• Signaling pathways responsible for cancer cell invasion as targets for cancer therapy.

  2004cites this paper
• Epidermal Growth Factor Receptor Inhibition in Cancer Therapy: Biology, Rationale and Preliminary Clinical Results

  2004cites this paper
• Epidermal growth factor receptor as a therapeutic target for the treatment of colorectal cancer.

  2004cites this paper
• Committee in charge

  2004cites this paper
• Protein kinase A and its role in human neoplasia: the Carney complex paradigm.

  2004cites this paper
• Minireview: PRKAR1A: normal and abnormal functions.

  2004cites this paper
• Targeted therapies in the treatment of pancreatic carcinoma

  2003cites this paper
• Synergistic antiproliferative and apoptotic effects induced by epidermal growth factor receptor and protein kinase a inhibitors in human prostatic cancer cell lines

  2003cites this paper
• New Advances on Prostate Carcinogenesis and Therapies: Involvement of EGF-EGFR Transduction System

  2003cites this paper
• Anti‐proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: Implication of epidermal growth factor receptor down‐regulation and ceramide production

  2003cites this paper
• Cyclic AMP mediated GSTP1 gene activation in tumor cells involves the interaction of activated CREB‐1 with the GSTP1 CRE: A novel mechanism of cellular GSTP1 gene regulation

  2002cites this paper
• Novel mechanism for regulation of epidermal growth factor receptor endocytosis revealed by protein kinase A inhibition.

  2002cites this paper
• Protein kinase A signaling: "cross-talk" with other pathways in endocrine cells.

  2002cites this paper
• Protein Kinase A and Chromosomal Stability

  2002cites this paper
• [The androgen receptor: molecular pathology].

  2002cites this paper
• Rolipram depresses [3H]2-deoxyglucose uptake in mouse brain and heart in vivo

  2002cites this paper
• Protein Kinase A Signaling

  2002cites this paper
• Protein Kinase A (PKA)

  2002cites this paper
• cAMP-dependent protein kinase and proliferation differ in normal and polycystic kidney epithelia.

  2002cites this paper
• The Jeremiah Metzger Lecture. Polycystic kidney disease: old disease in a new context.

  2002cites this paper
• Caveolin-1 phosphorylation in human squamous and epidermoid carcinoma cells: dependence on ErbB1 expression and Src activation.

  2002cites this paper
• Cell Condition-dependent Regulation of ERK5 by cAMP*

  2002cites this paper
• Novel Mechanism for Regulation of Epidermal Growth Factor Receptor Endocytosis Revealed by Protein Kinase A Inhibition

  2002cites this paper
• Anti‐proliferative effects of 8‐chloro‐cAMP and other cAMP analogs are unrelated to their effects on protein kinase A regulatory subunit expression

  2002cites this paper
• The epidermal growth factor receptor: a new target for anticancer therapy.

  2002cites this paper
• Overexpression of type I growth factor receptors in pterygium.

  2002cites this paper
• Epidermal growth factor stimulates proton efflux from chondrocytic cells

  2002cites this paper
• Secretory Phospholipase A2 Mediates Cooperative Prostaglandin Generation by Growth Factor and Cytokine Independently of Preceding Cytosolic Phospholipase A2 Expression in Rat Gastric Epithelial Cells*

  2001cites this paper
• Enhanced activity and level of protein kinase A in the spinal cord supernatant of diisopropyl phosphorofluoridate (DFP)-treated hens. Distribution of protein kinases and phosphatases in spinal cord subcellular fractions

  2001cites this paper
• Post-translational modifications of the regulatory subunits of cAMP-dependent protein kinases during G1/S progression.

  2001cites this paper
• Combined blockade of protein kinase A and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis.

  2001cites this paper
• Differentiation therapy of human cancer: basic science and clinical applications.

  2001cites this paper
• The expression of a mutant epidermal growth factor receptor in prostatic tumours

  2001cites this paper
• Treatment prospects for autosomal-dominant polycystic kidney disease.

  2001cites this paper
• Molecular Biology of the Androgen Receptor: From Molecular Understanding to the Clinic

  2001cites this paper
• Beta-Adrenergic, Arachidonic Acid and Potassium Channel Associated-Regulation of Human Breast Cancer Cell Lines

  2001cites this paper
• Distinctive Cyclic AMP-dependent Protein Kinase Subunit Localization Is Associated with Cyst Formation and Loss of Tubulogenic Capacity in Madin-Darby Canine Kidney Cell Clones*

  2000cites this paper
• Cyclic nucleotide analogs as biochemical tools and prospective drugs.

  2000cites this paper
• On receptor inhibitors and chemotherapy.

  2000cites this paper
• Oral antisense that targets protein kinase A cooperates with taxol and inhibits tumor growth, angiogenesis, and growth factor production.

  2000cites this paper
• The coordinated functional expression of epidermal growth factor receptor and c-Met in colorectal carcinoma metastasis.

  2000cites this paper
• Molecular events that regulate cell proliferation: an approach for the development of new anticancer drugs.

  2000cites this paper
• Growth inhibitors in the treatment of malignant neoplasms.

  2000cites this paper
• Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide.

  2000cites this paper
• Resistance to taxanes is induced by c‐erbB‐2 overexpression in human MCF‐10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting type I protein kinase A

  2000cites this paper
• Transforming growth factor alpha and mouse models of human breast cancer

  2000cites this paper
• Antisense and therapeutic oligonucleotides: toward a gene-targeting cancer clinic

  2000cites this paper
• Synergistic growth inhibition and induction of apoptosis by a novel mixed backbone antisense oligonucleotide targeting CRIPTO in combination with C225 anti-EGFR monoclonal antibody and 8-Cl-cAMP in human GEO colon cancer cells.

  1999cites this paper
• The epidermal growth factor receptor and its inhibition in cancer therapy.

  1999cites this paper
• Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225.

  1999cites this paper
• Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.

  1999cites this paper
• Effects of commonly used mitogens on the cytotoxicity of 4-tertiary butylphenol to human melanocytes

  1999cites this paper
• The immunohistochemical localization of phospholipase Cgamma and the epidermal growth-factor, platelet-derived growth-factor and fibroblast growth-factor receptors in the cells of the rat molar enamel organ during early amelogenesis.

  1999cites this paper
• Molecular mechanisms of resistance to taxanes and therapeutic implications.

  1999cites this paper
• Cooperative inhibitory effect of novel mixed backbone oligonucleotide targeting protein kinase A in combination with docetaxel and anti-epidermal growth factor-receptor antibody on human breast cancer cell growth.

  1999cites this paper